A Study of KNT-0916 in Treatment of Unresectable or Metastatic Solid Tumors With FGFR2 Alterations

Clinical trial NCT06800196 · RECRUITING

Trial details

NCT number: NCT06800196
Sponsor: KinoTeck Therapeutics Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors With FGFR2 Alterations, Adult

Start date: 2025-04-10
Primary completion: 2027-09-30
Enrollment: 151

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.